Treasury goes for Ksh.50 billion in extended bond offer


Treasury goes for Ksh.50 billion in extended bond offer
File Photo of The National Treasury.

In Summary

  • On Monday, the Central Bank of Kenya (CBK) announced the extended sale (tap sale) of two reopened 25-year Treasury bonds to July 1 which raised Ksh.19.7 billion earlier this month.
  • The extend sale will last through the remainder or June but is expected to close upon an early attainment of the Ksh.50 billion quantum.
  • The CBK which presents Treasury’s local debt issuer will be seeking to take advantage of high liquidity in the financial markets to firm up domestic borrowing early in the financial year.

Treasury has sought to raise Ksh.50 billion as it opens its local borrowing account for the 2021/22 financial year through an extended bond sale.

On Monday, the Central Bank of Kenya (CBK) announced the extended sale (tap sale) of two reopened 25-year Treasury bonds to July 1 which raised Ksh.19.7 billion earlier this month.

The extend sale will last through the remainder or June but is expected to close upon an early attainment of the Ksh.50 billion quantum.

The CBK which presents Treasury’s local debt issuer will be seeking to take advantage of high liquidity in the financial markets to firm up domestic borrowing early in the financial year.

This is as investors continue to favor the safe-haven investments in government securities as uncertainty remains in alternative investment classes such as private sector lending.

For instance, investors put in bids worth Ksh.65 billion in June’s primary sale in spite of the government only seeking Ksh.30 billion in proceeds.

Investors in the extended bond sale are expected to receive yields of 12.498 and 13.261 per cent which represents the average yield in the primary June auction.

The government is expected to borrow in excess of Ksh.660 billion, excluding redemption on local debt in the new fiscal year which opens on July 1.

For Citizen TV updates
Join @citizentvke Telegram channel



Video Of The Day: KEMRI scientists examine safety of anti-malarial drugs in first trimester of pregnancy

Avatar
Story By Kepha Muiruri
More by this author